BCL2L1 Anticorps
(BCL2-Like 1 (BCL2L1))
The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported. The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator. [provided by RefSeq, Jul 2008].
Recommandation
BCL2L1 Reactivité: Humain, Souris, Rat ICC, IF, IP, IHC (p), WB Hôte: Lapin Polyclonal unconjugated
Recommandation
BCL2L1 Reactivité: Humain IF, PLA, ELISA, WB Hôte: Souris Monoclonal 3E2-2A5 unconjugated
Recommandation
BCL2L1 Reactivité: Humain, Souris, Rat IHC (p), WB Hôte: Lapin Polyclonal unconjugated
BCL2L1 Anticorps par Hote
On trouve ici des BCL2L1 Anticorps avec un Hote spécifique. Les Hote mentionnés ici sont quelques-uns de ceux qui sont disponibles. Un clic sur le lien correspondant permet d'accéder aux produits
BCL2L1 Anticorps par Clonalité
Trouvez les BCL2L1 Anticorps monoclonaux ou polyclonaux disponibles. Cliquez sur un lien pour accéder aux produits correspondants.
BCL2L1 Anticorps fréquemment utilisés
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Mouse, Rat
Application
ICC, IF, IP, IHC (p), WB
Validations
- (1)
- (7)
N° du produit
ABIN2856151
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human, Mouse, Rat
Application
IHC (p), WB
Validations
- (4)
- (4)
N° du produit
ABIN5518741
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Application
IF, PLA, WB
Validations
- (5)
N° du produit
ABIN513678
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Application
ELISA, IF, IHC, WB
Validations
- (4)
N° du produit
ABIN7145294
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human, Mouse, Pig, Rat, Sheep
Application
ELISA, FACS, ICC, IF (cc), IF (p), IHC (fro), IHC (p), WB
Validations
- (7)
- (3)
N° du produit
ABIN675129
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human, Mouse, Rat
Application
ELISA, ICC, IF, IHC, WB
Validations
- (4)
N° du produit
ABIN6255430
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human, Mouse, Rat
Application
ELISA, ICC, IF, IHC, WB
Validations
- (4)
N° du produit
ABIN6260226
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
ELISA, IF, IHC, WB
Validations
- (4)
N° du produit
ABIN7193159
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
ELISA, IF, IHC
Validations
- (3)
N° du produit
ABIN7145298
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human, Mouse, Rat
Application
ELISA, ICC, IF, IHC, WB
Validations
- (3)
N° du produit
ABIN6260227
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Dog, Gerbil, Human, Mouse, Rat
Application
IHC, IHC (fro), IHC (p), IP, WB
Validations
- (3)
N° du produit
ABIN957161
Quantité
50 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
Coat, ELISA
Validations
- (3)
N° du produit
ABIN6940516
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Mouse
Application
ICC, IHC, WB
Validations
- (3)
N° du produit
ABIN1077850
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human, Rat
Application
IHC (p), WB
Validations
- (2)
- (2)
N° du produit
ABIN3043033
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human, Monkey
Application
IC, IF, IHC, WB
Validations
- (3)
N° du produit
ABIN7301510
Quantité
100 μL
Fiche technique
Fiche technique
Dernières publications pour nos BCL2L1 Anticorps
: "O‑GlcNAc modification influences endometrial receptivity by promoting endometrial cell proliferation, migration and invasion." dans: Oncology reports, Vol. 42, Issue 5, pp. 2065-2074, (2020) (PubMed).: "Integrated Proteomic and Transcriptomic Analysis Reveals Long Noncoding RNA HOX Transcript Antisense Intergenic RNA (HOTAIR) Promotes Hepatocellular Carcinoma Cell Proliferation by Regulating Opioid ..." dans: Molecular & cellular proteomics : MCP, Vol. 17, Issue 1, pp. 146-159, (2019) (PubMed).
: "Decrease in male mouse fertility by hydrogen sulfide and/or ammonia can Be inheritable." dans: Chemosphere, Vol. 194, pp. 147-157, (2018) (PubMed).
: "Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells." dans: Oncology reports, Vol. 38, Issue 3, pp. 1442-1450, (2018) (PubMed).
: "Emodin alleviates severe acute pancreatitis-associated acute lung injury by decreasing pre-B-cell colony-enhancing factor expression and promoting polymorphonuclear neutrophil apoptosis." dans: Molecular medicine reports, Vol. 16, Issue 4, pp. 5121-5128, (2018) (PubMed).
: "Grape Seed Proanthocyanidin Extract Prevents Ovarian Aging by Inhibiting Oxidative Stress in the Hens." dans: Oxidative medicine and cellular longevity, Vol. 2018, pp. 9390810, (2018) (PubMed).
: "Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model." dans: Naunyn-Schmiedeberg's archives of pharmacology, Vol. 390, Issue 4, pp. 379-395, (2017) (PubMed).
: "Photodynamic Therapy Using Indolines-Fused-Triazoles Induces Mitochondrial Apoptosis in Human Non-Melanoma BCC Cells." dans: Anticancer research, Vol. 37, Issue 10, pp. 5499-5505, (2017) (PubMed).
: "Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cells." dans: Oncology letters, Vol. 13, Issue 4, pp. 2059-2070, (2017) (PubMed).
: "Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models." dans: Molecular cancer therapeutics, Vol. 15, Issue 5, pp. 1132-44, (2016) (PubMed).
Pseudonymes pour BCL2L1 Anticorps
BCL2 like 1 (BCL2L1) AnticorpsBCL2-like 1 (Bcl2l1) Anticorps
Bcl2-like 1 (Bcl2l1) Anticorps
BCL2 like 1 (bcl2l1) Anticorps
BCL2-like 1 L homeolog (bcl2l1.L) Anticorps
BCL2 like 1 (Bcl2l1) Anticorps
bcl2-like 1 (bcl2l1) Anticorps
Bcl(X)L Anticorps
Bcl-X Anticorps
bcl-x Anticorps
bcl-X Anticorps
bcl-x(l) Anticorps
bcl-xL Anticorps
Bcl-XL Anticorps
Bcl-xl Anticorps
Bcl-xL Anticorps
BCL-XL Anticorps
bcl-XL Anticorps
bcl-xl Anticorps
BCL-XL/S Anticorps
bcl-xl/s Anticorps
bcl-xS Anticorps
Bcl-Xs Anticorps
bcl-xs Anticorps
BCL2L Anticorps
Bcl2l Anticorps
bcl2l Anticorps
BCL2L1 Anticorps
BCLX Anticorps
BclX Anticorps
Bclx Anticorps
bclx Anticorps
BCLXL Anticorps
bclxl Anticorps
BCLXS Anticorps
blp1 Anticorps
cb1021 Anticorps
PPP1R52 Anticorps
xR11 Anticorps
zfBLP1 Anticorps
Avez-vous cherché autre chose?
- BCL2A1 Anticorps
- BCL11B Anticorps
- BCL11A Anticorps
- BCL10 Anticorps
- Bcl-2 Anticorps
- BCKDK Anticorps
- BCKDHB Anticorps
- BCKDHA Anticorps
- BCDIN3D Anticorps
- BCCIP Anticorps
- BCAT2 Anticorps
- BCAT1 Anticorps
- BCAS3 Anticorps
- BCAS2 Anticorps
- BCAS1 Anticorps
- BCAR3 Anticorps
- BCAR1 Anticorps
- BCAP31 Anticorps
- BCAP29 Anticorps
- BCAN Anticorps
- BCL2L10 Anticorps
- BCL2L12 Anticorps
- BCL2L13 Anticorps
- BCL2L14 Anticorps
- BCL2L2 Anticorps
- BCL3 Anticorps
- BCL6 Anticorps
- BCL6B Anticorps
- BCL7A Anticorps
- BCL7B Anticorps
- BCL7C Anticorps
- BCL9 Anticorps
- BCL9L Anticorps
- BCLAF1 Anticorps
- BCMA Anticorps
- BCMO1 Anticorps
- BCO2 Anticorps
- BCOR Anticorps
- BCORL1 Anticorps
- BCR Anticorps
Vous êtes ici:
